Adicet Bio appoints Dr. Michael Kauffman to board of directors

Adicet Bio, Inc.

Appointed Michael Kauffman, M.D., Ph.D. to Board, effective Nov 17, 2021.
Dr. Kauffman is independent and will serve on the Nominating and Corporate Governance Committee.
Received option to purchase 37,000 shares at $9.39, vesting over 36 months.
Over 20 years industry experience; co-founder and former CEO of Karyopharm; led Velcade development.
Fills vacancy; board now includes three NCG committee members.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael Kauffman

Director

ACET · Adicet Bio, Inc.

Effective: 2021-11-17
Filed: November 18, 2021, 6:59 PM ET

On November 17, 2021, upon the recommendation of the Nominating and Corporate Governance Committee (the “NCG Committee”) of the board of directors (the “Board”) of Adicet Bio, Inc. (the “Company”), the Board appointed Michael Kauffman, M.D., Ph.D., to join the Board, effective as of November 17, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Kauffman was appointed as Director at Adicet Bio, Inc..

Action: appointed
Role: Director

Exact text from the filing

On November 17, 2021, upon the recommendation of the Nominating and Corporate Governance Committee (the “NCG Committee”) of the board of directors (the “Board”) of Adicet Bio, Inc. (the “Company”), the Board appointed Michael Kauffman, M.D., Ph.D., to join the Board, effective as of November 17, 2021.

View on SEC.gov

Adicet Bio, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-21-004750

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.